COVAXIN THIRD PHASE TRIAL

COVAXIN

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals

In what Hyderabad-based Bharat Biotech claims is the largest efficacy trial in India across 25 trial sites, the company claims its Covid-19 vaccine Covaxin is 65 per cent effective against the Delta variant. In a pre-print paper that is yet to be peer-reviewed, the company claimed that the vaccine is also 63 per cent effective …

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals Read More »

Bharat Biotech’s COVAXIN third phase trial begins

Bharat Biotech’s COVAXIN third phase trial begins

Third phase trial of potential corona virus vaccine of Bharat Biotech, Covaxin has begun. Haryana Health Minister Anil Vij was administered a trial dose of Covaxin at Ambala Cantonment. Mr. Anil Vij has become the first volunteer in the state for the third phase trial of the vaccine. He was kept under observation for some …

Bharat Biotech’s COVAXIN third phase trial begins Read More »